This statement addresses the need to provide clinically relevant and practical guidance for long-term care staff working in care homes and other stakeholders engaged in the care of residents who require consideration for dexamethasone and oxygen therapy. It had been provided following a series of consensus discussions between the EDWPOP and the EuGMS in January and February 2021. Its main aim is to minimise morbidity and mortality from serious acute illnesses including COVID-19 requiring these treatments within the long-term care sector.
All Keywords
【저자키워드】 COVID-19, Dexamethasone, oxygen, diabetes, Long-term care, 【초록키워드】 Treatment, Oxygen therapy, morbidity and mortality, Care, Guidance, Consensus, clinically, provided, illness, 【제목키워드】 Medicine, management, Algorithm, Oxygen therapy, Care, rapid response, Society, working, European,
【저자키워드】 COVID-19, Dexamethasone, oxygen, diabetes, Long-term care, 【초록키워드】 Treatment, Oxygen therapy, morbidity and mortality, Care, Guidance, Consensus, clinically, provided, illness, 【제목키워드】 Medicine, management, Algorithm, Oxygen therapy, Care, rapid response, Society, working, European,